MTOR and breast cancer: We found that, in iFLs induced by the reprogramming treatment of ROCK–mTOR inhibitors, expressions of a set of fat differentiation factors were increased by greater than tenfold (Fig. 3c), suggesting that these factors may be involved in breast cancer fat cell conversion.